Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dummer

Showing results (141-150 of 328) with videos related to

Pageof 33
Sort By:
The British Journal of Dermatology|September 5, 2002
A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphomaP M Carrozza, W Kempf, D V Kazakov, et al.
The British Journal of Dermatology|March 5, 2004
Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nmB M Prinz, S R Vavricka, P Graf, et al.
Oncogene|May 18, 2011
In melanoma, beta-catenin is a suppressor of invasionI Arozarena, H Bischof, D Gilby, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 28, 2016
ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumabY Nonomura, A Otsuka, M Ohtsuka, et al.
The British Journal of Dermatology|November 18, 2003
Imiquimod in basal cell carcinoma: how does it work?R Dummer, M Urosevic, W Kempf, et al.
Therapeutische Umschau. Revue Therapeutique|July 27, 1999
[Vaccination therapy of malignant melanoma]F O Nestle, A Tun Kyi, M Gilliet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2001
Serological detection of cutaneous T-cell lymphoma-associated antigensS Eichmuller, D Usener, R Dummer, et al.
Clinical and Experimental Immunology|January 1, 1993
Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expressionJ C Becker, A Schwinn, R Dummer, et al.
Dermatology (Basel, Switzerland)|July 9, 2004
Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoidesS Michaelis, A Cozzio, W Kempf, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Serum S100--a marker for disease monitoring in metastatic melanomaG Henze, R Dummer, H I Joller-Jemelka, et al.
Pageof 33

Showing results (141-150 of 328) with videos related to

Sort By:
Pageof 33
The British Journal of Dermatology|September 5, 2002
A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphomaP M Carrozza, W Kempf, D V Kazakov, et al.
The British Journal of Dermatology|March 5, 2004
Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nmB M Prinz, S R Vavricka, P Graf, et al.
Oncogene|May 18, 2011
In melanoma, beta-catenin is a suppressor of invasionI Arozarena, H Bischof, D Gilby, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 28, 2016
ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumabY Nonomura, A Otsuka, M Ohtsuka, et al.
The British Journal of Dermatology|November 18, 2003
Imiquimod in basal cell carcinoma: how does it work?R Dummer, M Urosevic, W Kempf, et al.
Therapeutische Umschau. Revue Therapeutique|July 27, 1999
[Vaccination therapy of malignant melanoma]F O Nestle, A Tun Kyi, M Gilliet, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2001
Serological detection of cutaneous T-cell lymphoma-associated antigensS Eichmuller, D Usener, R Dummer, et al.
Clinical and Experimental Immunology|January 1, 1993
Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expressionJ C Becker, A Schwinn, R Dummer, et al.
Dermatology (Basel, Switzerland)|July 9, 2004
Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoidesS Michaelis, A Cozzio, W Kempf, et al.
Dermatology (Basel, Switzerland)|January 1, 1997
Serum S100--a marker for disease monitoring in metastatic melanomaG Henze, R Dummer, H I Joller-Jemelka, et al.
Pageof 33